ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

hydronidone

Also written as “Hydronidone capsules”, “Hydronidone” and “Hydronidone (270mg)”.

Its studies are mostly in Liver Cirrhosis · Hepatitis B, Chronic · Renal Insufficiency, Chronic · Hepatitis B, led by 2 companies.

Drug pageHydronidone: every studyAll 15 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 3, since Oct 9, 202115 company-led studies, 3 open or runningNext primary completion: Dec 1, 2026 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
GNI Groupits history only143 open or runningphase 3since Oct 9, 2021Oct 9, 2019Dec 1, 2026phase 1 · NCT07262333
Shanghai Genomics10 open or runningphase 2since Jun 26, 2015Jun 26, 2015none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Shanghai Genomics only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jun 26, 2015First study: phase 2 study in Hepatitis B, ChronicFirst studyNCT02499562 · 168 enrolled · China

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

The one study Shanghai Genomics leads. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT02499562Hepatitis B, Chronic · China2CompletedNov 20, 2020168

How it is read

Names in the registry

  • “Hydronidone capsules”, 7 entries
  • “Hydronidone”, 4 entries
  • “Hydronidone (270mg)”, 1 entry
  • “[¹⁴C]Hydronidone”, 1 entry
  • “Hydronidone Capsules”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.